Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT06143137

Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up

Led by Artcline GmbH · Updated on 2024-08-02

142

Participants Needed

2

Research Sites

321 weeks

Total Duration

On this page

Sponsors

A

Artcline GmbH

Lead Sponsor

Z

ZKS Jena

Collaborating Sponsor

AI-Summary

What this Trial Is About

Subjects previously enrolled / randomized in the ReActIF-ICE (Recovery from acute immune failure in septic shock by immune cell extracorporeal terapy - immune competence enhancement) study received either standard sepsis treatment (control group) or standard sepsis treatment and additionally the ARTICE treatment (treatment group) during their index hospitalization. All subjects are followed up for 90 days after enrollment. In this long term follow up study, the enrolled subjects shall be followed up beyond 90 days for up to 5 years.

CONDITIONS

Official Title

Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject or legal surrogate is willing and able to provide written informed consent and comply with all protocol requirements or other established local procedures for consent if unable to provide consent.
  • Subject was enrolled in the ReActIF-ICE study.
  • Subject successfully passed the Day 2 re-evaluation of the ReActIF-ICE trial.
Not Eligible

You will not qualify if you...

  • None

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin

Magdeburg, Germany, 39130

Actively Recruiting

2

Universitätsmedizin Rostock, Abteilung KAI

Rostock, Germany

Actively Recruiting

Loading map...

Research Team

E

Erdmann J Zippel, RN

CONTACT

J

Jens Altrichter, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here